New Long-Lasting CAR-T Tech Prevents Cancer & HIV Relapse
1US researchers developed tech extending the lifespan of CAR-T immune cells.
2Unlike older methods, this allows cells to survive for years to prevent relapse.
3If commercialized, blood cancer and HIV patients could stay healthy much longer.
📖 Easy Explanation
🔍 Background
CAR-T is an advanced therapy that trains immune cells to attack cancer or viruses. While highly effective, the cells weaken over time, causing relapse in about half of patients.
📌 Key Points
US researchers created a new method allowing these cells to survive for years instead of weeks. By attaching special proteins, the cells continuously multiply and destroy harmful cells without exhaustion. Animal tests confirmed superior removal of infected cells.
💡 Why It Matters
If this technology becomes an actual treatment, patients with severe diseases like blood cancer or HIV can worry less about relapse. It brings hope for maintaining long-term health with just a single treatment.
🔮 What's Next
Although still in the research phase, we can expect it to be used in hospitals as a safe and effective treatment after undergoing human clinical trials.
📚 Glossary
카티 (CAR-T)A customized therapy that engineers a patient's immune cells to target and attack cancer cells or viruses.
HIVThe virus that causes AIDS (Acquired Immunodeficiency Syndrome).
사이토카인 (Cytokine)Special proteins that send signals to immune cells to help them survive and multiply.